Association between serum prolactin levels and neurodegenerative diseases: Systematic review and meta-analysis
Neuroimmunomodulation Oct 25, 2021
Duc Nguyen H, Hoang NMH, Ko M, et al. - Patients with Huntington’s disease and multiple sclerosis exhibited significantly higher serum prolactin (PRL) levels vs healthy controls. Serum PRL concentrations were related to age, region, and detection method.
PRL is thought to have a crucial role in the pathogenesis of neurodegenerative diseases (NDs).
This systematic review and meta-analysis involved 36 comparisons out of 29 studies (3 RCTs and 26 case controls), to examine serum PRL levels in patients with NDs.
Serum PRL levels did not differ statistically significantly between patients with NDs and healthy controls (standard mean difference SMD = 0.40).
Higher serum PRL levels were detected in patients with NDs aged <45 years (SMD = 0.97) vs healthy controls.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries